grants_govRFA-EB-28-004
Open
NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)
- Response deadline
- Dec 1, 2030 Due in 1499 days
- Date posted
- Oct 23, 2026
- Source
- Open notice
Description
This Notice of Funding Opportunity (NOFO) is to encourage applications from investigators to advance the development and translation of next-generation technologies to prevent, monitor, diagnose, and treat disorders within the missions of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) and The Helping to End Addiction Long-term (HEAL) Initiatives. Awarded activities will facilitate the translation of new devices up to the stage of readiness for first in human (FIH) clinical trials by overcoming key challenges identified during preliminary proof-of-concept studies. The scope of the program includes technology development and optimization, and studies to prepare for approvals for human use.
Classifications
- NAICS93.121
Documents (1)
- RFA-EB-28-004-Full-Announcement.htmltext/html;charset=UTF-8138 KBNot yet available
Contacts
Similar contracts
- Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)Due Sep 25, 2029
- Institutional Mentored Career Development Award (Parent K12) (Clinical Trials Not Allowed)Due Jul 12, 2029
- NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)Due Jul 5, 2029
- Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed)Due Jul 5, 2029
- NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)Due May 7, 2028
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)Due Nov 23, 2026